Evidence map›Paper›PMID 26258092›Full record

ArticleIranian journal of public health2015

Does Supplementation with Royal Jelly Improve Oxidative Stress and Insulin Resistance in Type 2 Diabetic Patients?

Farzad Shidfar, Shima Jazayeri, Seyedeh Neda Mousavi, Mojtaba Malek, Agha Fateme Hosseini, Basmeh Khoshpey

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Royal Jelly: Biological Action and Health Benefits.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Farzad ShidfarDept. of Nutrition, Iran University of Medical Sciences, Tehran, Iran.
Shima JazayeriDept. of Nutrition, Iran University of Medical Sciences, Tehran, Iran.
Seyedeh Neda MousaviDept. of Cellular & Molecular Nutrition, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba MalekResearch Center for Endocrinology and Metabolism, Institute of Endocrinology in Firouzgar Hospital, Iran University of Medical Sciences, Iran.
Agha Fateme HosseiniDept. of Statistics, School of Health Management and Information Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Basmeh KhoshpeyDept. of Nutrition, Iran University of Medical Sciences, Tehran, Iran.
Iran University of Medical Sciences · IRFiroozgar General Hospital · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnimal studies have shown antioxidant effects of Royal Jelly (RJ) and its effect on insulin resistance as the most common complication of Type 2 diabetes. This study was conducted to determine the effect of RJ intake on serum total antioxidant capacity, Malondialdehyde and insulin resistance in T2DM.

methodsIn this randomized controlled trial, forty-six type 2 diabetic patients, aged 25-65 years, with BMI of 20-30 kg/m(2), and HbA1c of 6-8% were included. The patients were randomly assigned to receive 1000 mg of RJ supplement or placebo, 3 times daily for 8 weeks. HOMA-IR, anthropometric measurements, fasting blood glucose, serum insulin, total antioxidant capacity and malondialdehyde level were measured.

resultsIn comparison with placebo, HOMA-IR decreased (P=0.015) while serum total antioxidant capacity increased significantly in RJ group (P=0.016). No significant difference was detected for serum insulin and MDA in two groups.

conclusionsRJ intake may have favorable effects on serum TAC and HOMA-IR in diabetic patients.

Indexed as

Insulin resistanceRoyal JellyTotal antioxidant capacityType 2 diabetes mellitus

Identifiers

PMID26258092
PMCPMC4524304
OpenAlexW2346224290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.